• OPEN AN ACCOUNT
Indian Indices
Sensex
80,056.92 746.91
( 0.94%)
Global Indices
Nasdaq
51,872.69 -1,504.43
(-2.82%)
Dow Jones
7,442.16 -267.46
(-3.47%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,776.27 -52.94
(-0.49%)
Forex
USD-INR
94.59 -0.14
(-0.15%)
EUR-INR
106.30 0.31
(0.29%)
GBP-INR
127.42 0.36
(0.28%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
43.29
83.19
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

dlf ltd
Remsons Industries consolidated net profit rises 14.73% in the March 2026 quarter
May 22,2026
Net profit of Remsons Industries rose 14.73% to Rs 5.22 crore in the quarter ended March 2026 as against Rs 4.55 crore during the previous quarter ended March 2025. Sales rose 22.81% to Rs 130.40 crore in the quarter ended March 2026 as against Rs 106.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 25.61% to Rs 18.05 crore in the year ended March 2026 as against Rs 14.37 crore during the previous year ended March 2025. Sales rose 24.46% to Rs 468.71 crore in the year ended March 2026 as against Rs 376.58 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales130.40106.18 23 468.71376.58 24
OPM %8.4210.32 -10.579.92 -
PBDT11.1810.17 10 46.2934.23 35
PBT5.398.45 -36 28.5322.56 26
NP5.224.55 15 18.0514.37 26